New MRI contrast agent detects invasive lung cancer earlier

Researchers have developed a new class of protein-based MRI contrast agent that detects invasive lung cancer and metastatic disease at earlier stages than conventional imaging approaches.

Results of this research in the journal Science Advances report a precision MRI method that can identify tumors and metasta...